These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24196120)

  • 41. Validation of macroscopic attenuated total reflection-Fourier transform infrared imaging to study dissolution of swelling pharmaceutical tablets.
    van der Weerd J; Kazarian SG
    Appl Spectrosc; 2004 Dec; 58(12):1413-9. PubMed ID: 15606953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of diffuse transmission mode in near-infrared quantification--part I: The press effect on low-dose pharmaceutical tablets.
    Saeed M; Saner S; Oelichmann J; Keller H; Betz G
    J Pharm Sci; 2009 Dec; 98(12):4877-86. PubMed ID: 19530070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Near infrared spectroscopy to monitor drug release in-situ during dissolution tests.
    Sarraguça MC; Matias R; Figueiredo R; Ribeiro PR; Martins AT; Lopes JA
    Int J Pharm; 2016 Nov; 513(1-2):1-7. PubMed ID: 27601336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Near-infrared spectral imaging for quality assurance of pharmaceutical products: analysis of tablets to assess powder blend homogeneity.
    Lyon RC; Lester DS; Lewis EN; Lee E; Yu LX; Jefferson EH; Hussain AS
    AAPS PharmSciTech; 2002; 3(3):E17. PubMed ID: 12916932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissolution assessment of allopurinol immediate release tablets by near infrared spectroscopy.
    Smetiško J; Miljanić S
    J Pharm Biomed Anal; 2017 Oct; 145():322-330. PubMed ID: 28709129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix Effects in Quantitative Assessment of Pharmaceutical Tablets Using Transmission Raman and Near-Infrared (NIR) Spectroscopy.
    Sparén A; Hartman M; Fransson M; Johansson J; Svensson O
    Appl Spectrosc; 2015 May; 69(5):580-9. PubMed ID: 25811389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Near-infrared spectroscopy as a nondestructive alternative to conventional tablet hardness testing.
    Morisseau KM; Rhodes CT
    Pharm Res; 1997 Jan; 14(1):108-11. PubMed ID: 9034230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clarification of the internal structure and factors of poor dissolution of substandard roxithromycin tablets by near-infrared chemical imaging.
    Sakuda M; Yoshida N; Koide T; Keila T; Kimura K; Tsuboi H
    Int J Pharm; 2021 Mar; 596():120232. PubMed ID: 33484929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complementary near-infrared and Raman chemical imaging of pharmaceutical thin films.
    Rozo JI; Zarow A; Zhou B; Pinal R; Iqbal Z; Romañach RJ
    J Pharm Sci; 2011 Nov; 100(11):4888-95. PubMed ID: 21656518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Applications of Fourier transform infrared spectroscopic imaging to tablet dissolution and drug release.
    Kazarian SG; Ewing AV
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1207-21. PubMed ID: 23682794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of Raman and Near-Infrared Chemical Mapping for the Analysis of Pharmaceutical Tablets.
    Carruthers H; Clark D; Clarke F; Faulds K; Graham D
    Appl Spectrosc; 2021 Feb; 75(2):178-188. PubMed ID: 32757763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Updating a near-infrared multivariate calibration model formed with lab-prepared pharmaceutical tablet types to new tablet types in full production.
    Farrell JA; Higgins K; Kalivas JH
    J Pharm Biomed Anal; 2012 Mar; 61():114-21. PubMed ID: 22154647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-comparing common calibration approaches.
    Ravn C; Skibsted E; Bro R
    J Pharm Biomed Anal; 2008 Nov; 48(3):554-61. PubMed ID: 18774667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
    Järvinen K; Hoehe W; Järvinen M; Poutiainen S; Juuti M; Borchert S
    Eur J Pharm Sci; 2013 Mar; 48(4-5):680-8. PubMed ID: 23313622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic resonance imaging of tablet dissolution.
    Nott KP
    Eur J Pharm Biopharm; 2010 Jan; 74(1):78-83. PubMed ID: 19602436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro quantitative ((1))H and ((19))F nuclear magnetic resonance spectroscopy and imaging studies of fluvastatin™ in Lescol® XL tablets in a USP-IV dissolution cell.
    Zhang Q; Gladden L; Avalle P; Mantle M
    J Control Release; 2011 Dec; 156(3):345-54. PubMed ID: 21911016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of transmission and reflection modalities for measuring content uniformity of pharmaceutical tablets with near-infrared spectroscopy.
    Xiang D; LoBrutto R; Cheney J; Wabuyele BW; Berry J; Lyon R; Wu H; Khan MA; Hussain AS
    Appl Spectrosc; 2009 Jan; 63(1):33-47. PubMed ID: 19146717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro monitoring of dissolution of an immediate release tablet by focused beam reflectance measurement.
    Coutant CA; Skibic MJ; Doddridge GD; Kemp CA; Sperry DC
    Mol Pharm; 2010 Oct; 7(5):1508-15. PubMed ID: 20715796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous FTIR spectroscopic imaging and visible photography to monitor tablet dissolution and drug release.
    Kazarian SG; van der Weerd J
    Pharm Res; 2008 Apr; 25(4):853-60. PubMed ID: 17612794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative polymorph contaminant analysis in tablets using Raman and near infra-red spectroscopies.
    Hennigan MC; Ryder AG
    J Pharm Biomed Anal; 2013 Jan; 72():163-71. PubMed ID: 23146243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.